Use of next-generation sequencing (NGS) to detect a novel ALK fusion and a high frequency of other actionable alterations in colorectal cancer (CRC).
Jeffrey S. Ross
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Research Funding - Foundation Medicine
Doron Lipson
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Christine E Sheehan
No relevant relationships to disclose
Geoff Otto
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Roman Yelensky
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Alex Parker
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Mirna Jarosz
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Frank Juhn
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Tina Brennan
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Sean Downing
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Amy Donahue
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Sohail Balasubramanian
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Gary A. Palmer
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Philip Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Maureen T. Cronin
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine